FDA Approved: NAPROXEN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Naproxen from Glenmark Pharmaceuticals to update the labeling for the generic product under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Bursitis
• Dysmenorrhea
• Gout
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis
• Tendinitis

Drugs mentioned

• Naproxen (Naproxen)

Snippet

SUPPL AP for NAPROXEN (NAPROXEN)